Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma

Sanjeev A. Vasudevan, Xiaoyi Shang, Shirong Chang, Ningling Ge, Jose L. Diaz-Miron, Heidi V. Russell, M. John Hicks, Andrew D. Ludwig, Catherine L. Wesson, Susan M. Burlingame, Eugene S. Kim, Javed Khan, Jianhua Yang and Jed G. Nuchtern
Sanjeev A. Vasudevan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyi Shang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shirong Chang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ningling Ge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose L. Diaz-Miron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi V. Russell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. John Hicks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew D. Ludwig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine L. Wesson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan M. Burlingame
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene S. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javed Khan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianhua Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jed G. Nuchtern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-08-1132 Published August 2009
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • NDSP, novel secreted factor in neuroblastoma - September 17, 2009

Abstract

Secreted proteins such as growth factors, cytokines, and chemokines play important roles in tumor development. Through expression microarray and bioinformatic analysis, we discovered a novel secreted protein, neuroblastoma-derived secretory protein (NDSP). The NDSP gene is found on chromosome 1q25.2 and encodes a 167 amino acid protein with a putative signal peptide. Using real-time PCR and immunoblotting, we find that NDSP is specifically overexpressed in neuroblastoma at much higher levels than other adult and pediatric malignancies and normal tissues. NDSP is an 18-kDa protein that can be secreted by NDSP-transfected HEK-293T cells, as well as, neuroblastoma cell lines endogenously expressing NDSP. Inhibiting NDSP expression in neuroblastoma cell lines with retrovirally transduced NDSP small hairpin interfering RNA, sh-NDSP, results in decreased cellular proliferation and colony formation. We also find inhibited extracellular signal-regulated kinase (ERK)1/2 phosphorylation in the sh-NDSP cell line. Treating the parental cell line with MAP/ERK kinase 1/2 inhibitors, which diminish ERK1/2 phosphorylation, results in decreased cell proliferation. Culturing these transduced cells with recombinant NDSP, reintroducing NDSP overexpression in the knockdown cell line, or inducing Ras oncogene overexpression for constitutive ERK1/2 activation results in a reversal of the growth-inhibited phenotype and proliferation rates similar to the control cells. In addition, reintroduction of NDSP overexpression in the sh-NDSP cell line results in ERK1/2 phosphorylation similar to control. We conclude that NDSP is specifically overexpressed in neuroblastoma and actively secreted from tumor cells. Furthermore, NDSP serves as a growth factor for neuroblastoma tumor cells through activation of the ERK-mediated proliferation pathway. [Mol Cancer Ther 2009;8(8):2478–89]

  • NDSP
  • secreted protein
  • neuroblastoma
  • extracellular signal regulated kinase

Footnotes

  • Grant support: Children's Oncology Group Translational Research Award (J.G. Nuchtern), National Cancer Institute grant 1R21CA106513-01A2 (J. Yang), Baylor College of Medicine Cancer Center Pilot Project grant (J. Yang), American Cancer Society grant RSG-06-070-01-TBE (J. Yang), Hope Street Kids Foundation (J. Yang), Bear Necessities Pediatric Cancer Foundation (J. Yang), Society of University Surgeons Ethicon Resident Scholarship (S.A.Vasudevan), and the NIH/National Cancer Institute-NRSA training grant 1F32CA113059-01A1 (S.A.Vasudevan).

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Note: Supplementary material for this article is available at Molecular Cancer Therapeutics Online (http://mct.aacrjournals.org/).

  • ↵6http://www.ncbi.nlm.nih.gov

  • ↵7http://www.ebi.ac.uk/scanps/

  • ↵8http://www.hypothesiscreator.net/iPSORT/index.html

  • ↵9http://home.ccr.cancer.gov/oncology/oncogenomics/

    • Received December 1, 2008.
    • Revision received May 6, 2009.
    • Accepted May 13, 2009.
  • © 2009 American Association for Cancer Research.
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 8 (8)
August 2009
Volume 8, Issue 8
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma
Sanjeev A. Vasudevan, Xiaoyi Shang, Shirong Chang, Ningling Ge, Jose L. Diaz-Miron, Heidi V. Russell, M. John Hicks, Andrew D. Ludwig, Catherine L. Wesson, Susan M. Burlingame, Eugene S. Kim, Javed Khan, Jianhua Yang and Jed G. Nuchtern
Mol Cancer Ther August 1 2009 (8) (8) 2478-2489; DOI: 10.1158/1535-7163.MCT-08-1132

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma
Sanjeev A. Vasudevan, Xiaoyi Shang, Shirong Chang, Ningling Ge, Jose L. Diaz-Miron, Heidi V. Russell, M. John Hicks, Andrew D. Ludwig, Catherine L. Wesson, Susan M. Burlingame, Eugene S. Kim, Javed Khan, Jianhua Yang and Jed G. Nuchtern
Mol Cancer Ther August 1 2009 (8) (8) 2478-2489; DOI: 10.1158/1535-7163.MCT-08-1132
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PX-478 Radiosensitization in Pancreatic Cancer
  • Metronomic Gemcitabine Inhibits Pancreatic Cancer
  • p53-Deficient Cells Are More Sensitive to Plk1 Inhibitor
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement